SCHEMBL21363789

SCHEMBL21363789

C=C(Cl)Cc1cc2c(cc1O)OCO2

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.40
PKM P14618 1/20 0.39
CYP3A4 P08684 3/20 0.38
CYP1A2 P05177 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMAD3 P84022 2/20 0.33
INSR P06213 2/20 0.33
IGF1R P08069 2/20 0.33
SRC P12931 2/20 0.33
CALM1 P0DP23 1/20 0.33
MAPT P10636 1/20 0.33
HSP90AA1 P07900 2/20 0.32
P4HB P07237 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363658 0.81 GAA (0.40) GAAPKMCYP3A4CYP1A2ALDH1A1
SCHEMBL14284022 0.76 CYP3A4 (0.46) GAAPKMCYP3A4CYP1A2CYP2C19
SCHEMBL14284021 0.76 CYP3A4 (0.46) GAAPKMCYP3A4CYP1A2CYP2C19
SCHEMBL28587493 0.76 ALDH1A1 (0.45) GAAPKMCYP3A4CYP1A2ALDH1A1
SCHEMBL1276635 0.73 CYP3A4 (0.55) GAAPKMCYP3A4CYP1A2ALDH1A1
SCHEMBL772701 0.72 HSP90AA1 (0.51) GAAPKMCYP3A4CYP1A2CYP2C19
SCHEMBL2268770 0.72 CYP3A4 (0.56) GAAPKMCYP3A4CYP1A2ALDH1A1
SCHEMBL10416171 0.72 GAA (0.63) GAAPKMCYP3A4ALDH1A1CYP2C19
SCHEMBL30928210 0.70 MEN1 (0.51) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL29226566 0.70 MEN1 (0.51) GAAALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed